🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Primary Breast Cancer

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites📍 Beverly Hills📍 San Francisco📍 Westwood, Los Angeles Fore Biotherapeutics · Tests: Plixorafenib Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity NCT04273061Phase 22 sites📍 Vancouver📍 Toronto British Columbia Cancer Agency · Tests: Atezolizumab Breast Cancer Proteomics and Molecular Heterogeneity NCT01840293n/a6 sites📍 Cork📍 Dublin📍 Dublin Cancer Trials Ireland Evaluation of the Efficacy and Safety of Using Platelet-rich Fibrin (PRF)-Based Lipobolus for the Immediate Reconstruction of Defects After Breast-conserving Resection for Breast Cancer (Minimally Invasive Primary Immediate Grafting) NCT07658170NA1 site📍 Saint Petersburg The Leningrad Regional Clinical Hospital · Tests: Lipobolus (Autologous Fat + Platelet-Rich Fibrin+Calcium chloride) Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer NCT07373782Phase 2, Phase 31 site📍 Leuven Universitaire Ziekenhuizen KU Leuven · Tests: Continuous Positive Airway Pressure (CPAP) Audit of Targeted Sentinel Node Biopsy (TSNB) in Patients With Limited Nodal Disease Undergoing Primary Surgery NCT07085442n/a14 sites📍 Burnley📍 Cambridge📍 Derby University Hospitals of Derby and Burton NHS Foundation Tru… · Tests: Targeted Sentinel Node Biopsy (TSNB) EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366Phase 1, Phase 266 sites📍 Phoenix📍 Tucson📍 Los Angeles Genmab · Tests: Rina-S, Carboplatin, Bevacizumab, Pembrolizumab, Erythromycin Sapu003 in Advanced mTOR-sensitive Solid Tumors NCT07369505Phase 11 site📍 Adelaide SAPU NANO (US) LLC · Tests: Sapu003, Exemestane 25 MG CBD for Breast Cancer Primary Tumors NCT06148038Phase 11 site📍 Charleston Medical University of South Carolina · Tests: CBD Oral, Control Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial) NCT03711110NA14 sites📍 Santiago de Compostela📍 Galdakao📍 Barcelona Fundación Instituto de Estudios de Ciencias de la Salud de … · Tests: Intensive cardiovascular monitoring, No intervention A Prospective Multicenter Study of the TuFEst-LN Model for Axillary Lymph Node Status Assessment in Breast Cancer NCT07304934n/a1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: No Intervention: Observational Cohort MELIORA Virtual Coach Intervention for Breast Cancer Prevention NCT07200427NA7 sites📍 Athens📍 Kaunas📍 Kaunas Harokopio University · Tests: MELIORA Virtual Coach Intervention, Control (generic advice) Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors NCT07586826Phase 21 site📍 Beijing Peking University People's Hospital · Tests: Romiplostim N01, All-trans retinoic acid Familial Investigations of Childhood Cancer Predisposition NCT03050268n/a1 site📍 Memphis St. Jude Children's Research Hospital Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax NCT05092373Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel, Tumor Treating Fields Therapy Evaluating the De-Escalation of Surveillance for Patients Who Have Undergone Curative Treatment for Breast Cancer NCT07572370n/a1 site📍 Dublin Royal College of Surgeons, Ireland · Tests: Deescalation of surveillance Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska Genomic Investigation of Unusual Responders NCT03740503n/a1 site📍 Toronto University Health Network, Toronto Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer NCT06856499Phase 12 sites📍 Aurora📍 Aurora University of Colorado, Denver · Tests: Cirtuvivint, Olaparib To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer NCT04660435n/a1 site📍 Prato Fondazione Sandro Pitigliani · Tests: Thymidine kinase activity Diet Modification in pAtients With Luminal Early Breast Cancer Candidate for Primary Surgery NCT04469296NA1 site📍 Montpellier Institut du Cancer de Montpellier - Val d'Aurelle · Tests: iso-caloric ketogenic diet, protein restricted diet Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer NCT00477100n/a10 sites📍 Gilbert📍 La Jolla📍 Greeley M.D. Anderson Cancer Center · Tests: Biospecimen Collection, Interview, Medical Chart Review, Questionnaire Administration Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial NCT05564377Phase 2484 sites📍 Birmingham📍 Mobile📍 Anchorage National Cancer Institute (NCI) · Tests: Alpelisib, Binimetinib, Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients NCT03561740Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: capecitabine Intravital Microscopy in Human Solid Tumors NCT03823144NA1 site📍 Jacksonville Mayo Clinic · Tests: Diagnostic Microscopy, Fluorescein Sodium Injection Subpectoral Plexus Block With Multi-level TPVB for Surgical Anesthesia During Primary Breast Cancer Surgery NCT04933266NA1 site📍 Sheung Shui Chinese University of Hong Kong · Tests: Subpectoral plexus block (low dose), Subpectoral plexus block (High dose) Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in Kenya NCT07764796NA1 site📍 Atlanta Emory University · Tests: Best Practice, Discussion, Interview - Stakeholder, Interview - Key Informant, Interview - Ancillary studies Metabolic Flexibility and Autonomic Control After Muscle Power vs Metabolic Power Training in Postmenopausal Oncological Women: the POWER Health Study NCT06336070NA1 site📍 Valencia University of Valencia · Tests: HIIT program (8 weeks), MPI program (8 weeks)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy